Article Details

Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years

Retrieved on: 2023-12-20 20:34:11

Tags for this article:

Click the tags to see associated articles and topics

Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years. View article details on hiswai:

Excerpt

And similar to the monoclonal antibodies, I think hopefully you do see recovery over time, which made a difference at least in some cases from ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo